Plus   Neg

AstraZeneca Pulls Back Off Best Levels But Remains Positive

After showing a strong upward move early in the session, shares of AstraZeneca (AZN) have given back some ground but remain positive in afternoon trading on Friday. AstraZeneca is currently up by 1.9 percent after reaching a six-month intraday high.

The early rally by AstraZeneca came after JPMorgan Chase upgraded its rating on the biopharmaceutical company to Overweight from Neutral.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
An administrative law judge has ruled that Minnesota regulators should approve Enbridge Inc.'s proposal to replace its aging Line 3 crude oil pipeline only if the company follows the existing route and not its preferred route. Enbridge has applied to replace its Line 3 pipeline from Alberta with new pipe along its existing route. In Minnesota, the planned route deviates from the existing route. CLICK HERE to see America's 10 Best-Selling Drugs Despite high drug costs, most of the top-selling drugs saw sales gains in 2017 compared to the prior year. A large number of the best-selling drugs are primarily for the treatment and management of cancer, diabetes, inflammatory disorders, and HIV... Most Americans have access to health care, though costs and services vary from state to state. However, higher costs do not necessarily translate into better results. The U.S. continues to be outperformed by other wealthy nations on several measures like life expectancy, disease burden and health...
Follow RTT